Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(chronic myeloid leukemia). Showing records 1 – 30 of 114 total matches.

[1] [2] [3] [4]

Search Limiters

Last 2 Years | English Only

Levels

Languages

Country

▼ Search Limiters


University of Adelaide

1. Hiwase, Devendra. Evaluation of anti-proliferative and pro-apoptotic effects of tyrosine kinase inhibitors on CML-CD34+ cells.

Degree: 2010, University of Adelaide

 Although imatinib (IM) has revolutionalised CML management, 30 to 40% patients fail IM therapy. Many of these patients can be rescued with second generation tyrosine… (more)

Subjects/Keywords: chronic myeloid leukemia; dasatinib; cytokines

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hiwase, D. (2010). Evaluation of anti-proliferative and pro-apoptotic effects of tyrosine kinase inhibitors on CML-CD34+ cells. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/65253

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hiwase, Devendra. “Evaluation of anti-proliferative and pro-apoptotic effects of tyrosine kinase inhibitors on CML-CD34+ cells.” 2010. Thesis, University of Adelaide. Accessed April 14, 2021. http://hdl.handle.net/2440/65253.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hiwase, Devendra. “Evaluation of anti-proliferative and pro-apoptotic effects of tyrosine kinase inhibitors on CML-CD34+ cells.” 2010. Web. 14 Apr 2021.

Vancouver:

Hiwase D. Evaluation of anti-proliferative and pro-apoptotic effects of tyrosine kinase inhibitors on CML-CD34+ cells. [Internet] [Thesis]. University of Adelaide; 2010. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2440/65253.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hiwase D. Evaluation of anti-proliferative and pro-apoptotic effects of tyrosine kinase inhibitors on CML-CD34+ cells. [Thesis]. University of Adelaide; 2010. Available from: http://hdl.handle.net/2440/65253

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Hong Kong

2. Kwan, Tsz-ki. The detection of BCR-ABL kinase domain mutation in the management of chronic myeloid leukemia.

Degree: 2008, University of Hong Kong

Subjects/Keywords: Chronic myeloid leukemia.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kwan, T. (2008). The detection of BCR-ABL kinase domain mutation in the management of chronic myeloid leukemia. (Thesis). University of Hong Kong. Retrieved from http://hdl.handle.net/10722/52028

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kwan, Tsz-ki. “The detection of BCR-ABL kinase domain mutation in the management of chronic myeloid leukemia.” 2008. Thesis, University of Hong Kong. Accessed April 14, 2021. http://hdl.handle.net/10722/52028.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kwan, Tsz-ki. “The detection of BCR-ABL kinase domain mutation in the management of chronic myeloid leukemia.” 2008. Web. 14 Apr 2021.

Vancouver:

Kwan T. The detection of BCR-ABL kinase domain mutation in the management of chronic myeloid leukemia. [Internet] [Thesis]. University of Hong Kong; 2008. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10722/52028.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kwan T. The detection of BCR-ABL kinase domain mutation in the management of chronic myeloid leukemia. [Thesis]. University of Hong Kong; 2008. Available from: http://hdl.handle.net/10722/52028

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Lund

3. Hansen, Nils. Functional Modeling of Genes Upregulated in Chronic Myeloid Leukemia.

Degree: 2013, University of Lund

Chronic myeloid leukemia (CML) is caused by the transformation of a primitive hematopoietic cell by the BCR/ABL1 fusion gene that is formed through the chromosomal… (more)

Subjects/Keywords: Medical Genetics; Chronic myeloid leukemia; SOCS2; IL1RAP; BCR/ABL1; leukemia models

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hansen, N. (2013). Functional Modeling of Genes Upregulated in Chronic Myeloid Leukemia. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/4143998 ; https://portal.research.lu.se/ws/files/3452298/4144000.pdf

Chicago Manual of Style (16th Edition):

Hansen, Nils. “Functional Modeling of Genes Upregulated in Chronic Myeloid Leukemia.” 2013. Doctoral Dissertation, University of Lund. Accessed April 14, 2021. https://lup.lub.lu.se/record/4143998 ; https://portal.research.lu.se/ws/files/3452298/4144000.pdf.

MLA Handbook (7th Edition):

Hansen, Nils. “Functional Modeling of Genes Upregulated in Chronic Myeloid Leukemia.” 2013. Web. 14 Apr 2021.

Vancouver:

Hansen N. Functional Modeling of Genes Upregulated in Chronic Myeloid Leukemia. [Internet] [Doctoral dissertation]. University of Lund; 2013. [cited 2021 Apr 14]. Available from: https://lup.lub.lu.se/record/4143998 ; https://portal.research.lu.se/ws/files/3452298/4144000.pdf.

Council of Science Editors:

Hansen N. Functional Modeling of Genes Upregulated in Chronic Myeloid Leukemia. [Doctoral Dissertation]. University of Lund; 2013. Available from: https://lup.lub.lu.se/record/4143998 ; https://portal.research.lu.se/ws/files/3452298/4144000.pdf

4. Grauers Wiktorin, Hanna. Redox reactions in cancer: impact and regulation.

Degree: 2018, University of Gothenburg / Göteborgs Universitet

 The reduction-oxidation (redox) reaction involves a change in the oxidation state of molecules where a molecule that donates an electron is oxidized and a molecule… (more)

Subjects/Keywords: Cancer; Immunotherapy; reactive oxygen species; NOX2; histamine dihydrochloride; myeloid-derived suppressor cells; checkpoint inhibition; acute myeloid leukemia; chronic myeloid leukemia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Grauers Wiktorin, H. (2018). Redox reactions in cancer: impact and regulation. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/56884

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Grauers Wiktorin, Hanna. “Redox reactions in cancer: impact and regulation.” 2018. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed April 14, 2021. http://hdl.handle.net/2077/56884.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Grauers Wiktorin, Hanna. “Redox reactions in cancer: impact and regulation.” 2018. Web. 14 Apr 2021.

Vancouver:

Grauers Wiktorin H. Redox reactions in cancer: impact and regulation. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2077/56884.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Grauers Wiktorin H. Redox reactions in cancer: impact and regulation. [Thesis]. University of Gothenburg / Göteborgs Universitet; 2018. Available from: http://hdl.handle.net/2077/56884

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


NSYSU

5. Chang Chien, Jung-Jung. Effect of quinacrine on Bcl-xL and Bcl-2 expression in human leukemia K562 cells.

Degree: Master, Institute of Biomedical Sciences, 2014, NSYSU

 Quinacrine, also known as mepacrine, is a drug applied on anti-protozoal and anti-rheumatic therapy. Moreover, quinacrine functioned as an intrapleural sclerosing agent as well. Although… (more)

Subjects/Keywords: Quinacrine; Chronic myeloid leukemia; Bcl-xL; Bcl-2; apoptosis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chang Chien, J. (2014). Effect of quinacrine on Bcl-xL and Bcl-2 expression in human leukemia K562 cells. (Thesis). NSYSU. Retrieved from http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0617114-144613

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chang Chien, Jung-Jung. “Effect of quinacrine on Bcl-xL and Bcl-2 expression in human leukemia K562 cells.” 2014. Thesis, NSYSU. Accessed April 14, 2021. http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0617114-144613.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chang Chien, Jung-Jung. “Effect of quinacrine on Bcl-xL and Bcl-2 expression in human leukemia K562 cells.” 2014. Web. 14 Apr 2021.

Vancouver:

Chang Chien J. Effect of quinacrine on Bcl-xL and Bcl-2 expression in human leukemia K562 cells. [Internet] [Thesis]. NSYSU; 2014. [cited 2021 Apr 14]. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0617114-144613.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chang Chien J. Effect of quinacrine on Bcl-xL and Bcl-2 expression in human leukemia K562 cells. [Thesis]. NSYSU; 2014. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0617114-144613

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Temple University

6. Maifrede, Silvia. EGR-1 TUMOR SUPPRESSOR IN BCR-ABL DRIVEN LEUKEMIA.

Degree: PhD, 2015, Temple University

Molecular Biology and Genetics

Chronic Myelogenous Leukemia (CML) is a hematological disease originated with a chromosomal translocation t(9;22)(q34;q11) in a pluripotent hematopoietic stem cell. CML… (more)

Subjects/Keywords: Molecular biology;

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Maifrede, S. (2015). EGR-1 TUMOR SUPPRESSOR IN BCR-ABL DRIVEN LEUKEMIA. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,321048

Chicago Manual of Style (16th Edition):

Maifrede, Silvia. “EGR-1 TUMOR SUPPRESSOR IN BCR-ABL DRIVEN LEUKEMIA.” 2015. Doctoral Dissertation, Temple University. Accessed April 14, 2021. http://digital.library.temple.edu/u?/p245801coll10,321048.

MLA Handbook (7th Edition):

Maifrede, Silvia. “EGR-1 TUMOR SUPPRESSOR IN BCR-ABL DRIVEN LEUKEMIA.” 2015. Web. 14 Apr 2021.

Vancouver:

Maifrede S. EGR-1 TUMOR SUPPRESSOR IN BCR-ABL DRIVEN LEUKEMIA. [Internet] [Doctoral dissertation]. Temple University; 2015. [cited 2021 Apr 14]. Available from: http://digital.library.temple.edu/u?/p245801coll10,321048.

Council of Science Editors:

Maifrede S. EGR-1 TUMOR SUPPRESSOR IN BCR-ABL DRIVEN LEUKEMIA. [Doctoral Dissertation]. Temple University; 2015. Available from: http://digital.library.temple.edu/u?/p245801coll10,321048


Rhodes University

7. Kibet, Caleb Kipkurui. Analysis of transcription factor binding specificity using ChIP-seq data.

Degree: MS, Faculty of Science, Biochemistry, Microbiology and Biotechnology, 2014, Rhodes University

 Transcription factors (TFs) are key regulators of gene expression whose failure has been implicated in many diseases, including cancer. They bind at various sites at… (more)

Subjects/Keywords: Transcription factors; Chronic myeloid leukemia; Antioncogenes; Cancer cells  – Growth  – Regulation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kibet, C. K. (2014). Analysis of transcription factor binding specificity using ChIP-seq data. (Masters Thesis). Rhodes University. Retrieved from http://hdl.handle.net/10962/d1013131

Chicago Manual of Style (16th Edition):

Kibet, Caleb Kipkurui. “Analysis of transcription factor binding specificity using ChIP-seq data.” 2014. Masters Thesis, Rhodes University. Accessed April 14, 2021. http://hdl.handle.net/10962/d1013131.

MLA Handbook (7th Edition):

Kibet, Caleb Kipkurui. “Analysis of transcription factor binding specificity using ChIP-seq data.” 2014. Web. 14 Apr 2021.

Vancouver:

Kibet CK. Analysis of transcription factor binding specificity using ChIP-seq data. [Internet] [Masters thesis]. Rhodes University; 2014. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10962/d1013131.

Council of Science Editors:

Kibet CK. Analysis of transcription factor binding specificity using ChIP-seq data. [Masters Thesis]. Rhodes University; 2014. Available from: http://hdl.handle.net/10962/d1013131

8. Saliba, Jessica. Activité anti-tumorale de l'EAPB0503, un nouveau composé imidazoquinoxaline, sur la Leucémie Myéloïde Chronique : Anti-tumoral properties of EAPB0503, a new imidazoquinoxaline compound, in Chronic Myeloid Leukemia.

Degree: Docteur es, Biologie Santé, 2013, Université Montpellier I

La leucémie myéloïde chronique (LMC) est une maladie myéloproliférative, résultant d'une translocation réciproque entre les chromosomes 9 et 22, donnant naissance à une kinase de… (more)

Subjects/Keywords: Imidazoquinoxalines; Leucemie myeloide chronique; Apoptose; Imidazoquinoxalines; Chronic Myeloid Leukemia; Apoptosis; 616

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Saliba, J. (2013). Activité anti-tumorale de l'EAPB0503, un nouveau composé imidazoquinoxaline, sur la Leucémie Myéloïde Chronique : Anti-tumoral properties of EAPB0503, a new imidazoquinoxaline compound, in Chronic Myeloid Leukemia. (Doctoral Dissertation). Université Montpellier I. Retrieved from http://www.theses.fr/2013MON13520

Chicago Manual of Style (16th Edition):

Saliba, Jessica. “Activité anti-tumorale de l'EAPB0503, un nouveau composé imidazoquinoxaline, sur la Leucémie Myéloïde Chronique : Anti-tumoral properties of EAPB0503, a new imidazoquinoxaline compound, in Chronic Myeloid Leukemia.” 2013. Doctoral Dissertation, Université Montpellier I. Accessed April 14, 2021. http://www.theses.fr/2013MON13520.

MLA Handbook (7th Edition):

Saliba, Jessica. “Activité anti-tumorale de l'EAPB0503, un nouveau composé imidazoquinoxaline, sur la Leucémie Myéloïde Chronique : Anti-tumoral properties of EAPB0503, a new imidazoquinoxaline compound, in Chronic Myeloid Leukemia.” 2013. Web. 14 Apr 2021.

Vancouver:

Saliba J. Activité anti-tumorale de l'EAPB0503, un nouveau composé imidazoquinoxaline, sur la Leucémie Myéloïde Chronique : Anti-tumoral properties of EAPB0503, a new imidazoquinoxaline compound, in Chronic Myeloid Leukemia. [Internet] [Doctoral dissertation]. Université Montpellier I; 2013. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2013MON13520.

Council of Science Editors:

Saliba J. Activité anti-tumorale de l'EAPB0503, un nouveau composé imidazoquinoxaline, sur la Leucémie Myéloïde Chronique : Anti-tumoral properties of EAPB0503, a new imidazoquinoxaline compound, in Chronic Myeloid Leukemia. [Doctoral Dissertation]. Université Montpellier I; 2013. Available from: http://www.theses.fr/2013MON13520


Brandeis University

9. Hollander, Klarissa. Understanding the Interplay Between Different Regulatory Features of Abl Kinase.

Degree: 2020, Brandeis University

 Abl is a member of the non-receptor tyrosine kinase family, a group of enzymes responsible for propagation of cell signals, including those responsible for cell… (more)

Subjects/Keywords: Kinase; Regulation; Tyrosine Kinase; Abl; Myristoylation; Phosphorylation; Chronic Myeloid Leukemia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hollander, K. (2020). Understanding the Interplay Between Different Regulatory Features of Abl Kinase. (Thesis). Brandeis University. Retrieved from http://hdl.handle.net/10192/37525

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hollander, Klarissa. “Understanding the Interplay Between Different Regulatory Features of Abl Kinase.” 2020. Thesis, Brandeis University. Accessed April 14, 2021. http://hdl.handle.net/10192/37525.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hollander, Klarissa. “Understanding the Interplay Between Different Regulatory Features of Abl Kinase.” 2020. Web. 14 Apr 2021.

Vancouver:

Hollander K. Understanding the Interplay Between Different Regulatory Features of Abl Kinase. [Internet] [Thesis]. Brandeis University; 2020. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10192/37525.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hollander K. Understanding the Interplay Between Different Regulatory Features of Abl Kinase. [Thesis]. Brandeis University; 2020. Available from: http://hdl.handle.net/10192/37525

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidade Estadual de Campinas

10. Carvalho, Fernanda de Cássia Frasson, 1978-. Avaliação da expressão dos genes TARP, ncTNFAIP8, IFNG, FASLG e AKT1 em pacientes com leucemia mieloide crônica resistentes ao imatinibe tratados com dasatinibe.

Degree: Faculdade de Ciências Médicas; Programa de Pós-Graduação em Clínica Médica, 2017, Universidade Estadual de Campinas

Orientador: Katia Borgia Barbosa Pagnano

Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas

Made available in DSpace on 2019-05-06T15:34:31Z (GMT). No. of… (more)

Subjects/Keywords: Leucemia mielóide crônica; Imatinibe; Dasatinibe; Chronic myeloid leukemia; Imatinib; Dasatinib

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Carvalho, Fernanda de Cássia Frasson, 1. (2017). Avaliação da expressão dos genes TARP, ncTNFAIP8, IFNG, FASLG e AKT1 em pacientes com leucemia mieloide crônica resistentes ao imatinibe tratados com dasatinibe. (Masters Thesis). Universidade Estadual de Campinas. Retrieved from http://repositorio.unicamp.br/jspui/handle/REPOSIP/333856

Chicago Manual of Style (16th Edition):

Carvalho, Fernanda de Cássia Frasson, 1978-. “Avaliação da expressão dos genes TARP, ncTNFAIP8, IFNG, FASLG e AKT1 em pacientes com leucemia mieloide crônica resistentes ao imatinibe tratados com dasatinibe.” 2017. Masters Thesis, Universidade Estadual de Campinas. Accessed April 14, 2021. http://repositorio.unicamp.br/jspui/handle/REPOSIP/333856.

MLA Handbook (7th Edition):

Carvalho, Fernanda de Cássia Frasson, 1978-. “Avaliação da expressão dos genes TARP, ncTNFAIP8, IFNG, FASLG e AKT1 em pacientes com leucemia mieloide crônica resistentes ao imatinibe tratados com dasatinibe.” 2017. Web. 14 Apr 2021.

Vancouver:

Carvalho, Fernanda de Cássia Frasson 1. Avaliação da expressão dos genes TARP, ncTNFAIP8, IFNG, FASLG e AKT1 em pacientes com leucemia mieloide crônica resistentes ao imatinibe tratados com dasatinibe. [Internet] [Masters thesis]. Universidade Estadual de Campinas; 2017. [cited 2021 Apr 14]. Available from: http://repositorio.unicamp.br/jspui/handle/REPOSIP/333856.

Council of Science Editors:

Carvalho, Fernanda de Cássia Frasson 1. Avaliação da expressão dos genes TARP, ncTNFAIP8, IFNG, FASLG e AKT1 em pacientes com leucemia mieloide crônica resistentes ao imatinibe tratados com dasatinibe. [Masters Thesis]. Universidade Estadual de Campinas; 2017. Available from: http://repositorio.unicamp.br/jspui/handle/REPOSIP/333856


Universidade Estadual de Campinas

11. Mascarenhas, Cintia do Couto, 1982-. Identificação e investigação de genes diferencialmente expressos entre pacientes com leucemia mielóide crônica e indivíduos controle.

Degree: Faculdade de Ciências Médicas; Programa de Pós-Graduação em Clínica Médica, 2013, Universidade Estadual de Campinas

Orientadores: Carmino Antonio de Souza, Fernando Ferreira Costa

Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas

Made available in DSpace on 2018-08-23T11:16:23Z… (more)

Subjects/Keywords: Leucemia mielóide crônica; Expressão gênica; Chronic myeloid leukemia; Gene expression

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mascarenhas, Cintia do Couto, 1. (2013). Identificação e investigação de genes diferencialmente expressos entre pacientes com leucemia mielóide crônica e indivíduos controle. (Doctoral Dissertation). Universidade Estadual de Campinas. Retrieved from MASCARENHAS, Cintia do Couto. Identificação e investigação de genes diferencialmente expressos entre pacientes com leucemia mielóide crônica e indivíduos controle. 2013. 178 p. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/308645>. Acesso em: 23 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/308645

Chicago Manual of Style (16th Edition):

Mascarenhas, Cintia do Couto, 1982-. “Identificação e investigação de genes diferencialmente expressos entre pacientes com leucemia mielóide crônica e indivíduos controle.” 2013. Doctoral Dissertation, Universidade Estadual de Campinas. Accessed April 14, 2021. MASCARENHAS, Cintia do Couto. Identificação e investigação de genes diferencialmente expressos entre pacientes com leucemia mielóide crônica e indivíduos controle. 2013. 178 p. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/308645>. Acesso em: 23 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/308645.

MLA Handbook (7th Edition):

Mascarenhas, Cintia do Couto, 1982-. “Identificação e investigação de genes diferencialmente expressos entre pacientes com leucemia mielóide crônica e indivíduos controle.” 2013. Web. 14 Apr 2021.

Vancouver:

Mascarenhas, Cintia do Couto 1. Identificação e investigação de genes diferencialmente expressos entre pacientes com leucemia mielóide crônica e indivíduos controle. [Internet] [Doctoral dissertation]. Universidade Estadual de Campinas; 2013. [cited 2021 Apr 14]. Available from: MASCARENHAS, Cintia do Couto. Identificação e investigação de genes diferencialmente expressos entre pacientes com leucemia mielóide crônica e indivíduos controle. 2013. 178 p. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/308645>. Acesso em: 23 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/308645.

Council of Science Editors:

Mascarenhas, Cintia do Couto 1. Identificação e investigação de genes diferencialmente expressos entre pacientes com leucemia mielóide crônica e indivíduos controle. [Doctoral Dissertation]. Universidade Estadual de Campinas; 2013. Available from: MASCARENHAS, Cintia do Couto. Identificação e investigação de genes diferencialmente expressos entre pacientes com leucemia mielóide crônica e indivíduos controle. 2013. 178 p. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/308645>. Acesso em: 23 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/308645


Universidade do Minho

12. Machado, Fátima Alexandra Meira. Development of a liposomal formulation for peptide delivery to serve as vaccine against chronic myeloid leukemia .

Degree: 2013, Universidade do Minho

 The main goal of this work was to characterize and explore the potential of Dioctadecyldimethylammonium Chloride (DODAC) / Monoolein (MO) liposomes in a 1:2 proportion… (more)

Subjects/Keywords: DODAC/MO (1:2); Chronic myeloid leukemia; BCR-ABL; Vaccines; Leucemia mielóide crónica; Vacinas

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Machado, F. A. M. (2013). Development of a liposomal formulation for peptide delivery to serve as vaccine against chronic myeloid leukemia . (Masters Thesis). Universidade do Minho. Retrieved from http://hdl.handle.net/1822/29422

Chicago Manual of Style (16th Edition):

Machado, Fátima Alexandra Meira. “Development of a liposomal formulation for peptide delivery to serve as vaccine against chronic myeloid leukemia .” 2013. Masters Thesis, Universidade do Minho. Accessed April 14, 2021. http://hdl.handle.net/1822/29422.

MLA Handbook (7th Edition):

Machado, Fátima Alexandra Meira. “Development of a liposomal formulation for peptide delivery to serve as vaccine against chronic myeloid leukemia .” 2013. Web. 14 Apr 2021.

Vancouver:

Machado FAM. Development of a liposomal formulation for peptide delivery to serve as vaccine against chronic myeloid leukemia . [Internet] [Masters thesis]. Universidade do Minho; 2013. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1822/29422.

Council of Science Editors:

Machado FAM. Development of a liposomal formulation for peptide delivery to serve as vaccine against chronic myeloid leukemia . [Masters Thesis]. Universidade do Minho; 2013. Available from: http://hdl.handle.net/1822/29422


Temple University

13. Morales, Kimberly. RAD52 DNA Binding Activity Can Be Targeted to Eliminate CML Stem Cells.

Degree: PhD, 2012, Temple University

Biology

BCR-ABL1 transforms hematopoietic stem cells into leukemia stem cells (LSCs) to induce chronic myeloid leukemia in chronic phase. Expression of BCR-ABL1 stimulates production of… (more)

Subjects/Keywords: Molecular biology; Oncology; Cellular biology; BCR-ABL1; chronic myeloid leukemia; DNA repair; RAD52; stem cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Morales, K. (2012). RAD52 DNA Binding Activity Can Be Targeted to Eliminate CML Stem Cells. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,190030

Chicago Manual of Style (16th Edition):

Morales, Kimberly. “RAD52 DNA Binding Activity Can Be Targeted to Eliminate CML Stem Cells.” 2012. Doctoral Dissertation, Temple University. Accessed April 14, 2021. http://digital.library.temple.edu/u?/p245801coll10,190030.

MLA Handbook (7th Edition):

Morales, Kimberly. “RAD52 DNA Binding Activity Can Be Targeted to Eliminate CML Stem Cells.” 2012. Web. 14 Apr 2021.

Vancouver:

Morales K. RAD52 DNA Binding Activity Can Be Targeted to Eliminate CML Stem Cells. [Internet] [Doctoral dissertation]. Temple University; 2012. [cited 2021 Apr 14]. Available from: http://digital.library.temple.edu/u?/p245801coll10,190030.

Council of Science Editors:

Morales K. RAD52 DNA Binding Activity Can Be Targeted to Eliminate CML Stem Cells. [Doctoral Dissertation]. Temple University; 2012. Available from: http://digital.library.temple.edu/u?/p245801coll10,190030

14. Deenik, Wendy. Prevention of Resistance in Chronic Myeloid Leukemia: the role of combination therapy.

Degree: 2010, Erasmus University Medical Center

 textabstractChronic myeloid leukemia (CML) is a rare disease with a worldwide incidence of approximately 1-2 cases per 100,000 individuals. Chronic myeloid leukemia occurs slightly more… (more)

Subjects/Keywords: chronic myeloid leukemia; combination therapy

…Dohme B.V. Bristol-Myers Squibb B.V. Prevention of Resistance in Chronic Myeloid Leukemia… …chronic phase chronic myeloid leukemia. A prospective randomized phase III study. (Ann… …intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia. (… …newly diagnosed patients with chronic myeloid leukemia. Result of the Dutch-Belgian HOVON-51… …leukemic and normal stem cell in the bone marrow of patients with chronic myeloid leukemia. (… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Deenik, W. (2010). Prevention of Resistance in Chronic Myeloid Leukemia: the role of combination therapy. (Doctoral Dissertation). Erasmus University Medical Center. Retrieved from http://hdl.handle.net/1765/17773

Chicago Manual of Style (16th Edition):

Deenik, Wendy. “Prevention of Resistance in Chronic Myeloid Leukemia: the role of combination therapy.” 2010. Doctoral Dissertation, Erasmus University Medical Center. Accessed April 14, 2021. http://hdl.handle.net/1765/17773.

MLA Handbook (7th Edition):

Deenik, Wendy. “Prevention of Resistance in Chronic Myeloid Leukemia: the role of combination therapy.” 2010. Web. 14 Apr 2021.

Vancouver:

Deenik W. Prevention of Resistance in Chronic Myeloid Leukemia: the role of combination therapy. [Internet] [Doctoral dissertation]. Erasmus University Medical Center; 2010. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1765/17773.

Council of Science Editors:

Deenik W. Prevention of Resistance in Chronic Myeloid Leukemia: the role of combination therapy. [Doctoral Dissertation]. Erasmus University Medical Center; 2010. Available from: http://hdl.handle.net/1765/17773


University of California – San Francisco

15. Reyes, Gabriel. Genetic Determinants of Disease Persistence and Overt Off-Target Resistance to TKI Therapy in Chronic Myeloid Leukemia.

Degree: Biomedical Sciences, 2014, University of California – San Francisco

Chronic myeloid leukemia (CML), driven by the fusion protein BCR-ABL1, remains highly responsive to treatment with tyrosine kinase inhibitors (TKIs). Although overt resistance and relapse… (more)

Subjects/Keywords: Biology; Medicine; Biochemistry; BCR-ABL; Chronic Myeloid Leukemia; EVI1; RAS; resistance; tyrosine kinase inhibitor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Reyes, G. (2014). Genetic Determinants of Disease Persistence and Overt Off-Target Resistance to TKI Therapy in Chronic Myeloid Leukemia. (Thesis). University of California – San Francisco. Retrieved from http://www.escholarship.org/uc/item/8xv839jk

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Reyes, Gabriel. “Genetic Determinants of Disease Persistence and Overt Off-Target Resistance to TKI Therapy in Chronic Myeloid Leukemia.” 2014. Thesis, University of California – San Francisco. Accessed April 14, 2021. http://www.escholarship.org/uc/item/8xv839jk.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Reyes, Gabriel. “Genetic Determinants of Disease Persistence and Overt Off-Target Resistance to TKI Therapy in Chronic Myeloid Leukemia.” 2014. Web. 14 Apr 2021.

Vancouver:

Reyes G. Genetic Determinants of Disease Persistence and Overt Off-Target Resistance to TKI Therapy in Chronic Myeloid Leukemia. [Internet] [Thesis]. University of California – San Francisco; 2014. [cited 2021 Apr 14]. Available from: http://www.escholarship.org/uc/item/8xv839jk.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Reyes G. Genetic Determinants of Disease Persistence and Overt Off-Target Resistance to TKI Therapy in Chronic Myeloid Leukemia. [Thesis]. University of California – San Francisco; 2014. Available from: http://www.escholarship.org/uc/item/8xv839jk

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Saskatchewan

16. Abrishami, Mahsa. GENERATION OF SYNTHETIC ANTIBODIES AS POTENTIAL THERAPEUTICS TO BLOCK IL3–MEDIATED INNATE IMATINIB RESISTANCE IN CHRONIC MEYLOID LEUKEMIA.

Degree: 2018, University of Saskatchewan

 This thesis was focused on generation of novel antibodies as therapeutics to block innate imatinib resistance in chronic myeloid leukemia (CML). Tyrosine kinase inhibitor (TKI),… (more)

Subjects/Keywords: Synthetic antibodies; IL-3; CML; Chronic myeloid leukemia; Imatinib; Innate Drug Resistance; Therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Abrishami, M. (2018). GENERATION OF SYNTHETIC ANTIBODIES AS POTENTIAL THERAPEUTICS TO BLOCK IL3–MEDIATED INNATE IMATINIB RESISTANCE IN CHRONIC MEYLOID LEUKEMIA. (Thesis). University of Saskatchewan. Retrieved from http://hdl.handle.net/10388/11711

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Abrishami, Mahsa. “GENERATION OF SYNTHETIC ANTIBODIES AS POTENTIAL THERAPEUTICS TO BLOCK IL3–MEDIATED INNATE IMATINIB RESISTANCE IN CHRONIC MEYLOID LEUKEMIA.” 2018. Thesis, University of Saskatchewan. Accessed April 14, 2021. http://hdl.handle.net/10388/11711.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Abrishami, Mahsa. “GENERATION OF SYNTHETIC ANTIBODIES AS POTENTIAL THERAPEUTICS TO BLOCK IL3–MEDIATED INNATE IMATINIB RESISTANCE IN CHRONIC MEYLOID LEUKEMIA.” 2018. Web. 14 Apr 2021.

Vancouver:

Abrishami M. GENERATION OF SYNTHETIC ANTIBODIES AS POTENTIAL THERAPEUTICS TO BLOCK IL3–MEDIATED INNATE IMATINIB RESISTANCE IN CHRONIC MEYLOID LEUKEMIA. [Internet] [Thesis]. University of Saskatchewan; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10388/11711.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Abrishami M. GENERATION OF SYNTHETIC ANTIBODIES AS POTENTIAL THERAPEUTICS TO BLOCK IL3–MEDIATED INNATE IMATINIB RESISTANCE IN CHRONIC MEYLOID LEUKEMIA. [Thesis]. University of Saskatchewan; 2018. Available from: http://hdl.handle.net/10388/11711

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

17. Moreira, Roberta Bitencourt. Caracterização de mutações que conferem resistência ao tratamento com imatinibe.

Degree: 2013, Universidade Federal do Espírito Santo; Mestrado em Biotecnologia; Programa de Pós-Graduação em Biotecnologia; UFES; BR

Made available in DSpace on 2016-08-29T15:34:30Z (GMT). No. of bitstreams: 1 tese_6281_Dissertação_Roberta Bitencourt Moreira_2013.pdf: 2949871 bytes, checksum: 0c46a98a4735b38e93978376b508fac6 (MD5) Previous issue date: 2013-03-06

A Leucemia… (more)

Subjects/Keywords: Leucemia Mielóide Crônica; Inibidores de tirosina cinase; Mutação; Chronic Myeloid Leukemia; Tyrosine Kinase Inhibitors; Mutation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Moreira, R. B. (2013). Caracterização de mutações que conferem resistência ao tratamento com imatinibe. (Masters Thesis). Universidade Federal do Espírito Santo; Mestrado em Biotecnologia; Programa de Pós-Graduação em Biotecnologia; UFES; BR. Retrieved from http://repositorio.ufes.br/handle/10/4464

Chicago Manual of Style (16th Edition):

Moreira, Roberta Bitencourt. “Caracterização de mutações que conferem resistência ao tratamento com imatinibe.” 2013. Masters Thesis, Universidade Federal do Espírito Santo; Mestrado em Biotecnologia; Programa de Pós-Graduação em Biotecnologia; UFES; BR. Accessed April 14, 2021. http://repositorio.ufes.br/handle/10/4464.

MLA Handbook (7th Edition):

Moreira, Roberta Bitencourt. “Caracterização de mutações que conferem resistência ao tratamento com imatinibe.” 2013. Web. 14 Apr 2021.

Vancouver:

Moreira RB. Caracterização de mutações que conferem resistência ao tratamento com imatinibe. [Internet] [Masters thesis]. Universidade Federal do Espírito Santo; Mestrado em Biotecnologia; Programa de Pós-Graduação em Biotecnologia; UFES; BR; 2013. [cited 2021 Apr 14]. Available from: http://repositorio.ufes.br/handle/10/4464.

Council of Science Editors:

Moreira RB. Caracterização de mutações que conferem resistência ao tratamento com imatinibe. [Masters Thesis]. Universidade Federal do Espírito Santo; Mestrado em Biotecnologia; Programa de Pós-Graduação em Biotecnologia; UFES; BR; 2013. Available from: http://repositorio.ufes.br/handle/10/4464


Universidade Estadual de Campinas

18. Almeida, Maria Helena de, 1973-. Aderência dos pacientes com leucemia mielóide crônica à terapia com inibidores de tirosino quinase.

Degree: Faculdade de Ciências Médicas; Programa de Pós-Graduação em Clínica Médica, 2013, Universidade Estadual de Campinas

Orientador: Cármino Antonio de Souza

Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas

Made available in DSpace on 2018-08-22T09:59:01Z (GMT). No. of… (more)

Subjects/Keywords: Adesão à medicação; Leucemia mielóide crônica; Terapêutica; Medication adherence; Chronic myeloid leukemia; Therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Almeida, Maria Helena de, 1. (2013). Aderência dos pacientes com leucemia mielóide crônica à terapia com inibidores de tirosino quinase. (Doctoral Dissertation). Universidade Estadual de Campinas. Retrieved from ALMEIDA, Maria Helena de. Aderência dos pacientes com leucemia mielóide crônica à terapia com inibidores de tirosino quinase. 2013. 164 p. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/308643>. Acesso em: 22 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/308643

Chicago Manual of Style (16th Edition):

Almeida, Maria Helena de, 1973-. “Aderência dos pacientes com leucemia mielóide crônica à terapia com inibidores de tirosino quinase.” 2013. Doctoral Dissertation, Universidade Estadual de Campinas. Accessed April 14, 2021. ALMEIDA, Maria Helena de. Aderência dos pacientes com leucemia mielóide crônica à terapia com inibidores de tirosino quinase. 2013. 164 p. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/308643>. Acesso em: 22 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/308643.

MLA Handbook (7th Edition):

Almeida, Maria Helena de, 1973-. “Aderência dos pacientes com leucemia mielóide crônica à terapia com inibidores de tirosino quinase.” 2013. Web. 14 Apr 2021.

Vancouver:

Almeida, Maria Helena de 1. Aderência dos pacientes com leucemia mielóide crônica à terapia com inibidores de tirosino quinase. [Internet] [Doctoral dissertation]. Universidade Estadual de Campinas; 2013. [cited 2021 Apr 14]. Available from: ALMEIDA, Maria Helena de. Aderência dos pacientes com leucemia mielóide crônica à terapia com inibidores de tirosino quinase. 2013. 164 p. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/308643>. Acesso em: 22 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/308643.

Council of Science Editors:

Almeida, Maria Helena de 1. Aderência dos pacientes com leucemia mielóide crônica à terapia com inibidores de tirosino quinase. [Doctoral Dissertation]. Universidade Estadual de Campinas; 2013. Available from: ALMEIDA, Maria Helena de. Aderência dos pacientes com leucemia mielóide crônica à terapia com inibidores de tirosino quinase. 2013. 164 p. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/308643>. Acesso em: 22 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/308643

19. Davies, Samuel. Desenvolvimento, caracterização e efeitos biológicos de nanocápsulas poliméricas contendo ácido lipóico e/ou resveratrol.

Degree: 2019, Brazil

O interesse no uso de antioxidantes na prevenção e tratamento de diferentes patologias vem ganhando espaço nos últimos anos, uma vez que a desregulação do… (more)

Subjects/Keywords: Resveratrol; Ácido lipóico; Nanocápsulas; Antioxidantes; Leucemia mielóide crônica; Lipoic acid; Nanocapsules; Antioxidants; Chronic myeloid leukemia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Davies, S. (2019). Desenvolvimento, caracterização e efeitos biológicos de nanocápsulas poliméricas contendo ácido lipóico e/ou resveratrol. (Doctoral Dissertation). Brazil. Retrieved from http://hdl.handle.net/10183/201595

Chicago Manual of Style (16th Edition):

Davies, Samuel. “Desenvolvimento, caracterização e efeitos biológicos de nanocápsulas poliméricas contendo ácido lipóico e/ou resveratrol.” 2019. Doctoral Dissertation, Brazil. Accessed April 14, 2021. http://hdl.handle.net/10183/201595.

MLA Handbook (7th Edition):

Davies, Samuel. “Desenvolvimento, caracterização e efeitos biológicos de nanocápsulas poliméricas contendo ácido lipóico e/ou resveratrol.” 2019. Web. 14 Apr 2021.

Vancouver:

Davies S. Desenvolvimento, caracterização e efeitos biológicos de nanocápsulas poliméricas contendo ácido lipóico e/ou resveratrol. [Internet] [Doctoral dissertation]. Brazil; 2019. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10183/201595.

Council of Science Editors:

Davies S. Desenvolvimento, caracterização e efeitos biológicos de nanocápsulas poliméricas contendo ácido lipóico e/ou resveratrol. [Doctoral Dissertation]. Brazil; 2019. Available from: http://hdl.handle.net/10183/201595


Universidade Estadual de Campinas

20. Rego, Monica Fortes Napoleão do, 1960-. Leucemia mieloide crônica : aspectos clínicos e fatores que infuenciaram a resposta citogenética em pacientes tratados com imatinibe no estado do Piauí.

Degree: Faculdade de Ciências Médicas; Programa de Pós-Graduação em Ciências Médicas, 2014, Universidade Estadual de Campinas

Orientador: Irene Gyongyver Heidemarie Lorand Metze

Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas

Made available in DSpace on 2018-08-26T02:52:00Z (GMT). No.… (more)

Subjects/Keywords: Leucemia mielóide crônica; Análise citogenética; Prognóstico; Epidemiologia; Chronic myeloid leukemia; Cytogenetic analysis; Prognosis; Epidemiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rego, Monica Fortes Napoleão do, 1. (2014). Leucemia mieloide crônica : aspectos clínicos e fatores que infuenciaram a resposta citogenética em pacientes tratados com imatinibe no estado do Piauí. (Doctoral Dissertation). Universidade Estadual de Campinas. Retrieved from REGO, Monica Fortes Napoleão do. Leucemia mieloide crônica: aspectos clínicos e fatores que infuenciaram a resposta citogenética em pacientes tratados com imatinibe no estado do Piauí. 2014. 71 f. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/312722>. Acesso em: 25 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/312722

Chicago Manual of Style (16th Edition):

Rego, Monica Fortes Napoleão do, 1960-. “Leucemia mieloide crônica : aspectos clínicos e fatores que infuenciaram a resposta citogenética em pacientes tratados com imatinibe no estado do Piauí.” 2014. Doctoral Dissertation, Universidade Estadual de Campinas. Accessed April 14, 2021. REGO, Monica Fortes Napoleão do. Leucemia mieloide crônica: aspectos clínicos e fatores que infuenciaram a resposta citogenética em pacientes tratados com imatinibe no estado do Piauí. 2014. 71 f. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/312722>. Acesso em: 25 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/312722.

MLA Handbook (7th Edition):

Rego, Monica Fortes Napoleão do, 1960-. “Leucemia mieloide crônica : aspectos clínicos e fatores que infuenciaram a resposta citogenética em pacientes tratados com imatinibe no estado do Piauí.” 2014. Web. 14 Apr 2021.

Vancouver:

Rego, Monica Fortes Napoleão do 1. Leucemia mieloide crônica : aspectos clínicos e fatores que infuenciaram a resposta citogenética em pacientes tratados com imatinibe no estado do Piauí. [Internet] [Doctoral dissertation]. Universidade Estadual de Campinas; 2014. [cited 2021 Apr 14]. Available from: REGO, Monica Fortes Napoleão do. Leucemia mieloide crônica: aspectos clínicos e fatores que infuenciaram a resposta citogenética em pacientes tratados com imatinibe no estado do Piauí. 2014. 71 f. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/312722>. Acesso em: 25 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/312722.

Council of Science Editors:

Rego, Monica Fortes Napoleão do 1. Leucemia mieloide crônica : aspectos clínicos e fatores que infuenciaram a resposta citogenética em pacientes tratados com imatinibe no estado do Piauí. [Doctoral Dissertation]. Universidade Estadual de Campinas; 2014. Available from: REGO, Monica Fortes Napoleão do. Leucemia mieloide crônica: aspectos clínicos e fatores que infuenciaram a resposta citogenética em pacientes tratados com imatinibe no estado do Piauí. 2014. 71 f. Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/312722>. Acesso em: 25 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/312722

21. Hallner, Alexander. Immunotherapy and immunosuppression in myeloid leukemia.

Degree: 2018, University of Gothenburg / Göteborgs Universitet

 Acute myeloid leukemia (AML) and chronic myelomonocytic leukemia (CMML) are potentially life-threatening blood cancers characterized by the expansion of malignant myeloid cells in bone marrow… (more)

Subjects/Keywords: Natural killer cells; acute myeloid leukemia; histamine dihydrochloride; immunotherapy; reactive oxygen species; chronic myelomonocytic leukemia; NK cell education; NKG2A; HLA; KIR

Page 1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hallner, A. (2018). Immunotherapy and immunosuppression in myeloid leukemia. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/56919

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hallner, Alexander. “Immunotherapy and immunosuppression in myeloid leukemia.” 2018. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed April 14, 2021. http://hdl.handle.net/2077/56919.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hallner, Alexander. “Immunotherapy and immunosuppression in myeloid leukemia.” 2018. Web. 14 Apr 2021.

Vancouver:

Hallner A. Immunotherapy and immunosuppression in myeloid leukemia. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2077/56919.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hallner A. Immunotherapy and immunosuppression in myeloid leukemia. [Thesis]. University of Gothenburg / Göteborgs Universitet; 2018. Available from: http://hdl.handle.net/2077/56919

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of New South Wales

22. Hughes, Timothy Peter. Clinical and biological significance of minimal residual disease in patients treated for chronic myeloid leukaemia.

Degree: Medicine. Medicine, 1991, University of New South Wales

Subjects/Keywords: Myeloid leukemia; Leukemia; Chronic diseases; Thesis Digitisation Program

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hughes, T. P. (1991). Clinical and biological significance of minimal residual disease in patients treated for chronic myeloid leukaemia. (Masters Thesis). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/67210 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:67935/SOURCE01?view=true

Chicago Manual of Style (16th Edition):

Hughes, Timothy Peter. “Clinical and biological significance of minimal residual disease in patients treated for chronic myeloid leukaemia.” 1991. Masters Thesis, University of New South Wales. Accessed April 14, 2021. http://handle.unsw.edu.au/1959.4/67210 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:67935/SOURCE01?view=true.

MLA Handbook (7th Edition):

Hughes, Timothy Peter. “Clinical and biological significance of minimal residual disease in patients treated for chronic myeloid leukaemia.” 1991. Web. 14 Apr 2021.

Vancouver:

Hughes TP. Clinical and biological significance of minimal residual disease in patients treated for chronic myeloid leukaemia. [Internet] [Masters thesis]. University of New South Wales; 1991. [cited 2021 Apr 14]. Available from: http://handle.unsw.edu.au/1959.4/67210 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:67935/SOURCE01?view=true.

Council of Science Editors:

Hughes TP. Clinical and biological significance of minimal residual disease in patients treated for chronic myeloid leukaemia. [Masters Thesis]. University of New South Wales; 1991. Available from: http://handle.unsw.edu.au/1959.4/67210 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:67935/SOURCE01?view=true


University of Helsinki

23. Rebane, Anni. Overcoming Drug-resistance in Chronic Myeloid Leukemia.

Degree: Medicinska fakulteten, 2015, University of Helsinki

 Given the success of first-line treatment in chronic myeloid leukemia (CML), the prevalence of the disease is estimated to increase and more patients are expected… (more)

Subjects/Keywords: Chronic myeloid leukemia; CML; leukemia; drug-resistance; point mutations; BCR-ABL1; T315I; T315M; E255V/T315I; high-throughput screening; combination testing; Chronic myeloid leukemia; CML; leukemia; drug-resistance; point mutations; BCR-ABL1; T315I; T315M; E255V/T315I; high-throughput screening; combination testing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rebane, A. (2015). Overcoming Drug-resistance in Chronic Myeloid Leukemia. (Masters Thesis). University of Helsinki. Retrieved from http://hdl.handle.net/10138/231375

Chicago Manual of Style (16th Edition):

Rebane, Anni. “Overcoming Drug-resistance in Chronic Myeloid Leukemia.” 2015. Masters Thesis, University of Helsinki. Accessed April 14, 2021. http://hdl.handle.net/10138/231375.

MLA Handbook (7th Edition):

Rebane, Anni. “Overcoming Drug-resistance in Chronic Myeloid Leukemia.” 2015. Web. 14 Apr 2021.

Vancouver:

Rebane A. Overcoming Drug-resistance in Chronic Myeloid Leukemia. [Internet] [Masters thesis]. University of Helsinki; 2015. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10138/231375.

Council of Science Editors:

Rebane A. Overcoming Drug-resistance in Chronic Myeloid Leukemia. [Masters Thesis]. University of Helsinki; 2015. Available from: http://hdl.handle.net/10138/231375

24. Isber, Marc. Caractérisation d’aptamères ADN inhibiteurs de l’activité de STAT5B, une protéine impliquée dans les leucémies : Caracterization of DNA aptamers inhibitors of STAT5B activity, a protein involved in leukemia.

Degree: Docteur es, Biotechnologie, 2016, Compiègne

STAT5A et B sont des facteurs de transcription qui constituent le point de convergence de nombreux signaux extracellulaires. Parmi leurs fonctions biologiques, ils sont connus… (more)

Subjects/Keywords: Leucémogenèse; STAT5B; Apta1; Apta2; Cellules hématopoïétiques; SELEX (Systematic Evolution of Ligands by EXponential enrichment); DNA; Leukemogenesis; Chronic myeloid leukemia; Hematopoiesis; Leukemia inhibitory factor; Leukemia; Transcription factors; Proteins; Oligonucleotides

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Isber, M. (2016). Caractérisation d’aptamères ADN inhibiteurs de l’activité de STAT5B, une protéine impliquée dans les leucémies : Caracterization of DNA aptamers inhibitors of STAT5B activity, a protein involved in leukemia. (Doctoral Dissertation). Compiègne. Retrieved from http://www.theses.fr/2016COMP2305

Chicago Manual of Style (16th Edition):

Isber, Marc. “Caractérisation d’aptamères ADN inhibiteurs de l’activité de STAT5B, une protéine impliquée dans les leucémies : Caracterization of DNA aptamers inhibitors of STAT5B activity, a protein involved in leukemia.” 2016. Doctoral Dissertation, Compiègne. Accessed April 14, 2021. http://www.theses.fr/2016COMP2305.

MLA Handbook (7th Edition):

Isber, Marc. “Caractérisation d’aptamères ADN inhibiteurs de l’activité de STAT5B, une protéine impliquée dans les leucémies : Caracterization of DNA aptamers inhibitors of STAT5B activity, a protein involved in leukemia.” 2016. Web. 14 Apr 2021.

Vancouver:

Isber M. Caractérisation d’aptamères ADN inhibiteurs de l’activité de STAT5B, une protéine impliquée dans les leucémies : Caracterization of DNA aptamers inhibitors of STAT5B activity, a protein involved in leukemia. [Internet] [Doctoral dissertation]. Compiègne; 2016. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2016COMP2305.

Council of Science Editors:

Isber M. Caractérisation d’aptamères ADN inhibiteurs de l’activité de STAT5B, une protéine impliquée dans les leucémies : Caracterization of DNA aptamers inhibitors of STAT5B activity, a protein involved in leukemia. [Doctoral Dissertation]. Compiègne; 2016. Available from: http://www.theses.fr/2016COMP2305

25. Ma, Leyuan. Targeting Drug Resistance in Chronic Myeloid Leukemia: A Dissertation.

Degree: Interdisciplinary Graduate Program, Molecular, Cell, and Cancer Biology Department, 2016, U of Massachusetts : Med

  Inhibiting BCR-ABL kinase activity with tyrosine kinase inhibitors (TKIs) has been the frontline therapy for CML. Resistance to TKIs frequently occurs, but the mechanisms… (more)

Subjects/Keywords: Leukemia; Myelogenous; Chronic; BCR-ABL Positive; Antineoplastic Agents; Drug Resistance; Neoplasm; Chronic Myeloid Leukemia; Cellular and Molecular Physiology; Hemic and Lymphatic Diseases; Medicinal Chemistry and Pharmaceutics; Neoplasms; Oncology; Pharmacology; Therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ma, L. (2016). Targeting Drug Resistance in Chronic Myeloid Leukemia: A Dissertation. (Doctoral Dissertation). U of Massachusetts : Med. Retrieved from http://escholarship.umassmed.edu/gsbs_diss/870

Chicago Manual of Style (16th Edition):

Ma, Leyuan. “Targeting Drug Resistance in Chronic Myeloid Leukemia: A Dissertation.” 2016. Doctoral Dissertation, U of Massachusetts : Med. Accessed April 14, 2021. http://escholarship.umassmed.edu/gsbs_diss/870.

MLA Handbook (7th Edition):

Ma, Leyuan. “Targeting Drug Resistance in Chronic Myeloid Leukemia: A Dissertation.” 2016. Web. 14 Apr 2021.

Vancouver:

Ma L. Targeting Drug Resistance in Chronic Myeloid Leukemia: A Dissertation. [Internet] [Doctoral dissertation]. U of Massachusetts : Med; 2016. [cited 2021 Apr 14]. Available from: http://escholarship.umassmed.edu/gsbs_diss/870.

Council of Science Editors:

Ma L. Targeting Drug Resistance in Chronic Myeloid Leukemia: A Dissertation. [Doctoral Dissertation]. U of Massachusetts : Med; 2016. Available from: http://escholarship.umassmed.edu/gsbs_diss/870


Freie Universität Berlin

26. Oberender, Christian. Sequenzierung des NUMB-Gens in Patienten mit Chronischer Myeloischer Leukämie.

Degree: 2014, Freie Universität Berlin

 Ein besseres Verständnis der molekularbiologischen Vorgänge, die zur Transformation der chronischen myeloischen Leukämie (CML) von der relativ indolenten chronischen Phase (CP) zur fatalen Blastenkrise führen,… (more)

Subjects/Keywords: chronic myeloid leukemia; chronic myelogenous leukemia; CML; NUMB; Sequencing; MSI2; Musashi; blast crisis; progression; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Oberender, C. (2014). Sequenzierung des NUMB-Gens in Patienten mit Chronischer Myeloischer Leukämie. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-13110

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Oberender, Christian. “Sequenzierung des NUMB-Gens in Patienten mit Chronischer Myeloischer Leukämie.” 2014. Thesis, Freie Universität Berlin. Accessed April 14, 2021. http://dx.doi.org/10.17169/refubium-13110.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Oberender, Christian. “Sequenzierung des NUMB-Gens in Patienten mit Chronischer Myeloischer Leukämie.” 2014. Web. 14 Apr 2021.

Vancouver:

Oberender C. Sequenzierung des NUMB-Gens in Patienten mit Chronischer Myeloischer Leukämie. [Internet] [Thesis]. Freie Universität Berlin; 2014. [cited 2021 Apr 14]. Available from: http://dx.doi.org/10.17169/refubium-13110.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Oberender C. Sequenzierung des NUMB-Gens in Patienten mit Chronischer Myeloischer Leukämie. [Thesis]. Freie Universität Berlin; 2014. Available from: http://dx.doi.org/10.17169/refubium-13110

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

27. Cabanas, Hélène. Rôle de la signalisation calcique dans la leucémie myéloïde chronique : Role of calcium signaling in chronic myeloid leukemia.

Degree: Docteur es, Aspects moléculaires et cellulaires de la biologie, 2016, Poitiers

La Leucémie Myéloïde Chronique (LMC) est une maladie clonale caractérisée par la présence du chromosome Philadelphie codant pour Bcr-Abl, une tyrosine kinase constitutivement active responsable… (more)

Subjects/Keywords: Leucémie myéloïde chronique; Homéostasie calcique; STIM1/Orai1/TRPC1; Leucémogenèse; Chronic myeloid leukemia; Calcium homeostasis; STIM1/Orai1/TRPC1; Leukemogenesis; 571.6

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cabanas, H. (2016). Rôle de la signalisation calcique dans la leucémie myéloïde chronique : Role of calcium signaling in chronic myeloid leukemia. (Doctoral Dissertation). Poitiers. Retrieved from http://www.theses.fr/2016POIT2302

Chicago Manual of Style (16th Edition):

Cabanas, Hélène. “Rôle de la signalisation calcique dans la leucémie myéloïde chronique : Role of calcium signaling in chronic myeloid leukemia.” 2016. Doctoral Dissertation, Poitiers. Accessed April 14, 2021. http://www.theses.fr/2016POIT2302.

MLA Handbook (7th Edition):

Cabanas, Hélène. “Rôle de la signalisation calcique dans la leucémie myéloïde chronique : Role of calcium signaling in chronic myeloid leukemia.” 2016. Web. 14 Apr 2021.

Vancouver:

Cabanas H. Rôle de la signalisation calcique dans la leucémie myéloïde chronique : Role of calcium signaling in chronic myeloid leukemia. [Internet] [Doctoral dissertation]. Poitiers; 2016. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2016POIT2302.

Council of Science Editors:

Cabanas H. Rôle de la signalisation calcique dans la leucémie myéloïde chronique : Role of calcium signaling in chronic myeloid leukemia. [Doctoral Dissertation]. Poitiers; 2016. Available from: http://www.theses.fr/2016POIT2302


Erasmus University Rotterdam

28. Geelen, Inge. Population-based Registry and Response Monitoring in Chronic Myeloid Leukemia.

Degree: Department of Hematology, 2018, Erasmus University Rotterdam

 textabstractObservational studies of the efficacy and safety of tyrosine kinase inhibitor (TKI) treatment in patients with chronic myeloid leukemia (CML) who did not participate in… (more)

Subjects/Keywords: Chronic myeloid leukemia (CML); population-based registry; response monitoring

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Geelen, I. (2018). Population-based Registry and Response Monitoring in Chronic Myeloid Leukemia. (Doctoral Dissertation). Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/111330

Chicago Manual of Style (16th Edition):

Geelen, Inge. “Population-based Registry and Response Monitoring in Chronic Myeloid Leukemia.” 2018. Doctoral Dissertation, Erasmus University Rotterdam. Accessed April 14, 2021. http://hdl.handle.net/1765/111330.

MLA Handbook (7th Edition):

Geelen, Inge. “Population-based Registry and Response Monitoring in Chronic Myeloid Leukemia.” 2018. Web. 14 Apr 2021.

Vancouver:

Geelen I. Population-based Registry and Response Monitoring in Chronic Myeloid Leukemia. [Internet] [Doctoral dissertation]. Erasmus University Rotterdam; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1765/111330.

Council of Science Editors:

Geelen I. Population-based Registry and Response Monitoring in Chronic Myeloid Leukemia. [Doctoral Dissertation]. Erasmus University Rotterdam; 2018. Available from: http://hdl.handle.net/1765/111330

29. M. Barcella. MAPPING BCR-ABL1 FUSION POINTS IN CHRONIC MYELOID LEUKEMIA BY NEXT GENERATION SEQUENCING.

Degree: 2014, Università degli Studi di Milano

Chronic myeloid leukemia (CML) is a myeloproliferative disorder cytogenetically characterized by a reciprocal translocation between the long arms of chromosome 9 and 22 t(9;22) that… (more)

Subjects/Keywords: chronic myeloid leukemia; next generation sequencing; bioinformatics; BCR-ABL1; Philadelphia chromosome; MRD; translocations; Settore MED/04 - Patologia Generale

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Barcella, M. (2014). MAPPING BCR-ABL1 FUSION POINTS IN CHRONIC MYELOID LEUKEMIA BY NEXT GENERATION SEQUENCING. (Thesis). Università degli Studi di Milano. Retrieved from http://hdl.handle.net/2434/231153

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Barcella, M.. “MAPPING BCR-ABL1 FUSION POINTS IN CHRONIC MYELOID LEUKEMIA BY NEXT GENERATION SEQUENCING.” 2014. Thesis, Università degli Studi di Milano. Accessed April 14, 2021. http://hdl.handle.net/2434/231153.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Barcella, M.. “MAPPING BCR-ABL1 FUSION POINTS IN CHRONIC MYELOID LEUKEMIA BY NEXT GENERATION SEQUENCING.” 2014. Web. 14 Apr 2021.

Vancouver:

Barcella M. MAPPING BCR-ABL1 FUSION POINTS IN CHRONIC MYELOID LEUKEMIA BY NEXT GENERATION SEQUENCING. [Internet] [Thesis]. Università degli Studi di Milano; 2014. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2434/231153.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Barcella M. MAPPING BCR-ABL1 FUSION POINTS IN CHRONIC MYELOID LEUKEMIA BY NEXT GENERATION SEQUENCING. [Thesis]. Università degli Studi di Milano; 2014. Available from: http://hdl.handle.net/2434/231153

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

30. Josselin, Marina. Etude des rétrotransposons LINE-1 dans la leucémie myéloïde chronique : LINE-1 retrotransposon in chronic myeloid leukemia.

Degree: Docteur es, Sciences, technologie, santé. Génétique, 2012, Université de Bordeaux Segalen

Le gène hybride BCR-ABL1, responsable de la leucémie myéloïde chronique (LMC), code une protéine à activité tyrosine kinase constitutive. Lors d’une étude transcriptomique menée au… (more)

Subjects/Keywords: Rétrotransposons LINE-1; Leucémie myéloïde chronique; Instabilité génétique; Réparation de l’ADN; LINE-1 retrotransposons, , ,; Chronic myeloid leukemia; Genomic instability; DNA repair

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Josselin, M. (2012). Etude des rétrotransposons LINE-1 dans la leucémie myéloïde chronique : LINE-1 retrotransposon in chronic myeloid leukemia. (Doctoral Dissertation). Université de Bordeaux Segalen. Retrieved from http://www.theses.fr/2012BOR21985

Chicago Manual of Style (16th Edition):

Josselin, Marina. “Etude des rétrotransposons LINE-1 dans la leucémie myéloïde chronique : LINE-1 retrotransposon in chronic myeloid leukemia.” 2012. Doctoral Dissertation, Université de Bordeaux Segalen. Accessed April 14, 2021. http://www.theses.fr/2012BOR21985.

MLA Handbook (7th Edition):

Josselin, Marina. “Etude des rétrotransposons LINE-1 dans la leucémie myéloïde chronique : LINE-1 retrotransposon in chronic myeloid leukemia.” 2012. Web. 14 Apr 2021.

Vancouver:

Josselin M. Etude des rétrotransposons LINE-1 dans la leucémie myéloïde chronique : LINE-1 retrotransposon in chronic myeloid leukemia. [Internet] [Doctoral dissertation]. Université de Bordeaux Segalen; 2012. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2012BOR21985.

Council of Science Editors:

Josselin M. Etude des rétrotransposons LINE-1 dans la leucémie myéloïde chronique : LINE-1 retrotransposon in chronic myeloid leukemia. [Doctoral Dissertation]. Université de Bordeaux Segalen; 2012. Available from: http://www.theses.fr/2012BOR21985

[1] [2] [3] [4]

.